Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,237 | -15,374 | -22,886 | -29,418 | -21,281 |
| Depreciation Amortization | 66 | 71 | 71 | 58 | 28 |
| Accounts receivable | 5,000 | -5,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,408 | -266 | 1,111 | -473 | 938 |
| Other Working Capital | -7,401 | 13,450 | 3,081 | -2,818 | 3,347 |
| Other Operating Activity | -4,087 | 6,985 | 1,595 | 3,143 | 380 |
| Operating Cash Flow | $-30,252 | $-135 | $-17,027 | $-29,507 | $-16,588 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -171 | -55 | -11 | -179 | -96 |
| Investing Cash Flow | $-171 | $-55 | $-11 | $-179 | $-96 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,530 | 4,000 | N/A | N/A | N/A |
| Debt Repayment | -725 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 9,237 | 3,139 | 10,160 | 92 | 42,710 |
| Other Financing Activity | 0 | 0 | 563 | 0 | 0 |
| Financing Cash Flow | $20,042 | $7,139 | $10,722 | $92 | $42,710 |
| Beginning Cash Position | 12,711 | 5,762 | 12,078 | 41,671 | 15,644 |
| End Cash Position | 2,329 | 12,711 | 5,762 | 12,078 | 41,671 |
| Net Cash Flow | $-10,382 | $6,949 | $-6,316 | $-29,594 | $26,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,252 | -135 | -17,027 | -29,507 | -16,588 |
| Capital Expenditure | -171 | -55 | -11 | -179 | -96 |
| Free Cash Flow | -30,423 | -190 | -17,038 | -29,686 | -16,683 |